Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories established Pharmaceuticals — Global Manufacturing Facilities (Sites)
Form 10-K Item 2 (Properties — Manufacturing Sites by Reportable Segment)
Latest, FY2025
22
Period ended Dec 31, 2025
Change on a year earlier
-4.3%
23 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Established Pharmaceuticals — Global Manufacturing Facilities (Sites) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22 | -4.3% | SEC Filing (0001628280-26-010185) ↗ |
| FY2024 | Dec 31, 2024 | 23 | -4.2% | SEC Filing (0001628280-25-007110) ↗ |
| FY2023 | Dec 31, 2023 | 24 | 0.0% | SEC Filing (0001628280-24-005348) ↗ |
| FY2022 | Dec 31, 2022 | 24 | -4.0% | SEC Filing (0001628280-23-004026) ↗ |
| FY2021 | Dec 31, 2021 | 25 | -10.7% | SEC Filing (0001104659-22-025141) ↗ |
| FY2020 | Dec 31, 2020 | 28 | 0.0% | SEC Filing (0001104659-21-025751) ↗ |
| FY2019 | Dec 31, 2019 | 28 | -6.7% | SEC Filing (0001104659-20-023904) ↗ |
| FY2018 | Dec 31, 2018 | 30 | -3.2% | SEC Filing (0001047469-19-000624) ↗ |
| FY2017 | Dec 31, 2017 | 31 | – | SEC Filing (0001047469-18-000856) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Established Pharmaceuticals — Global Manufacturing Facilities (Sites), annual FY2017–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/epd-mfg-sites
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.